Descovy (Emtricitabine / Tenofovir Alafenamide Fumarate)

Save over 55% on brand Descovy from Europe and over 80% on generic Descovy.

Click here for information on Emcure generics (Immediate availability)

For brand Descovy, Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.

According to the European Medicines Agency, brand name Descovy originating from Europe is manufactured at the following site(s):Gilead Sciences Ireland UC IDA Business & Technology Park Carrigtohill County Cork Ireland

Prescription Descovy is taken for the treatment of HIV-1 in combination with other medicines in people 12 years and up who weigh at least 77 pounds. Descovy does not cure HIV-1 but is used as part of the treatment of HIV.

Descovy is a reverse transcriptase inhibitor, inhibiting the virus from reproducing and spreading reducing the amount of HIV in the blood, holding off damage to immune system and development of subsequent diseases and infections associated with AIDS.

The most exciting discover with Descovy is in use for prevention of HIV. Descovy is used once daily reduce the risk of getting the HIV-1 virus in men. who have vaginal sex with women. Descovy  has not been studies in prevention of HIV in homosexual activity.

In 2019, when comparing Descovy cost to USA Descovy coupon price, InsulinHub was found to offer a discount of approximately 40% in Descovy savings. 

Buy Descovy from InsulinHub.com for the best Descovy cost.

Information about Descovy (Emtricitabine / Tenofovir Alafenamide Fumarate)

Descovy is a prescription medication that combines two antiretroviral agents: emtricitabine and tenofovir alafenamide fumarate. It is used in the treatment of HIV-1 infection and as part of pre-exposure prophylaxis (PrEP) to prevent HIV infection in at-risk individuals.

Product Highlights

• Used as part of a comprehensive HIV-1 treatment regimen in combination with other antiretroviral medications.
• Used to reduce the risk of HIV-1 infection in individuals at high risk when taken consistently and correctly.

Key Ingredient

• Emtricitabine
• Tenofovir Alafenamide Fumarate

Key Benefits

• Helps maintain low viral loads in HIV-positive individuals, reducing the risk of developing AIDS and other HIV-related complications.
• Significantly lowers the risk of contracting HIV when used as prescribed for PrEP.
• Tenofovir alafenamide has a better safety profile compared to older forms of tenofovir, with less impact on kidney function and bone density.

Direction of Use

• Take one tablet daily by mouth with or without food.
• For PrEP, it is crucial to adhere to the daily dosing schedule for maximum effectiveness.
• For HIV treatment, Descovy should be used in combination with other antiretroviral agents as part of a complete treatment plan.

Dose of Descovy according to third agent in the HIV treatment regimen

Safety Concerns

• Potential side effects include nausea, diarrhea, headache, fatigue, and potential effects on kidney function and bone mineral density.
• Regular monitoring of kidney function and bone health is recommended, especially for long-term users.
• Can interact with other medications, including certain antiviral drugs and medications that affect kidney function.

Avoid Descovy (Emtricitabine / Tenofovir Alafenamide Fumarate) If

• You have a known hypersensitivity to emtricitabine, tenofovir alafenamide, or any other components of Descovy.
• It should not be used for PrEP in individuals who are HIV-positive or have undiagnosed HIV infection.
• Avoid use in individuals with severe renal impairment or end-stage renal disease, as it may exacerbate kidney issues.
• Caution is advised if you have significant liver disease, osteoporosis, or other conditions that could be affected by changes in bone density or renal function.